Glycopyrrolate: Medgend

Glycopyrrolate FDA Approved Drugs

BEVESPI AEROSPHERE [Formoterol Fumarate^{2C₁₉H₂₄N₂O₄C₄H₄O₄2H₂O} : Glycopyrrolate^{C₁₉H₂₈NO₃Br}]

0.0048mg/inh : 0.0090mg/inh (inhalation aerosol, metered)

Astrazeneca Pharms^{Apr 25, 2016}

Use in the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CUVPOSA [Glycopyrrolate^{C₁₉H₂₈NO₃Br}]

1mg/5ml (oral solution)

Merz Pharms^{Jul 28, 2010}

Reduce chronic severe drooling (i.e., sialorrhea) in patients with neurologic conditions associated with problem drooling.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GLYCOPYRROLATE [Glycopyrrolate^{C₁₉H₂₈NO₃Br}]

0.2mg/ml (injection injectable)

1.5mg (oral tablet)

1mg (oral tablet)

Amneal Pharms Co^{Jun 15, 2017}
Hikma Farmaceutica^{Sep 21, 2011}
Luitpold^{Jul 23, 1986}
Somerset Theraps Llc^{Jun 23, 2017}
Nexgen Pharma^{Mar 12, 2012}
Appco Pharma Llc^{Jan 3, 2017}
Aurolife Pharma Llc^{Apr 15, 2013}
Dr Reddys Labs Ltd^{Mar 21, 2008}
Leading Pharma Llc^{Sep 21, 2012}
Natco Pharma Ltd^{Jun 20, 2016}
Par Pharm^{Aug 31, 2006}
Rising Pharms Inc^{Dec 29, 2008}
Santos Biotech^{Feb 3, 2014}
Sun Pharm Inds Ltd^{Aug 18, 2009}
Vintage Pharms^{Oct 19, 2011}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ROBINUL [Glycopyrrolate^{C₁₉H₂₈NO₃Br}]

1mg (oral tablet)

Casper Pharma Llc^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ROBINUL FORTE [Glycopyrrolate^{C₁₉H₂₈NO₃Br}]

2mg (oral tablet)

Casper Pharma Llc^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SEEBRI [Glycopyrrolate^{C₁₉H₂₈NO₃Br}]

15.6mcg/inh (inhalation powder)

Sunovion Pharms Inc^{Oct 29, 2015}

Long - term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

UTIBRON [Glycopyrrolate^{C₁₉H₂₈NO₃Br} : Indacaterol Maleate^{C₂₄H₂₈N₂O₃C₄H₄O₄}]

15.6mcg/inh : 27.5mcg/inh (inhalation powder)

Sunovion Pharms Inc^{Oct 29, 2015}

Long - term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.